A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
PHASE2WithdrawnINTERVENTIONAL
0
Timeline
Start Date
September 30, 2012
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
Conditions
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
NCT01655186 - A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter